CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Veracyte will pay NanoString $50 million in cash and Veracyte stock plus up to $10 million in cash upon the commercial launch of Veracyte diagnostic tests for use on the nCounter platform.
Veracyte, 650-243-6300
NanoString, 888-358-6266
Pages: 1 2
Veracyte will pay NanoString $50 million in cash and Veracyte stock plus up to $10 million in cash upon the commercial launch of Veracyte diagnostic tests for use on the nCounter platform.
Veracyte, 650-243-6300
NanoString, 888-358-6266
Tagged with: NanoString Technologies Veracyte